Partner Ron Eppen is quoted in a Law360 article, “A Guide to Marijuana Legalization in Massachusetts,” about the implementation of a new law legalizing the recreational use of marijuana.
If Massachusetts follows in the path of Colorado and other states that have already legalized marijuana, Eppen said, the small not-profit dispensaries now operated by people who are in it for the culture will likely be replaced by big for-profit corporations that are in it for the money.
“What you’ve seen as the type of dollars that are involved have gotten larger and larger, is a professionalization of cannabis companies, in terms of their management,” he said. “Along with this has come basically a rush of investors who are looking to get in on the action, because the types of returns you can get from investment in a cannabis company are significantly more beneficial to investors than a typical early stage venture capital.”
If Massachusetts follows in the path of Colorado and other states that have already legalized marijuana, Eppen said, the small not-profit dispensaries now operated by people who are in it for the culture will likely be replaced by big for-profit corporations that are in it for the money.
“What you’ve seen as the type of dollars that are involved have gotten larger and larger, is a professionalization of cannabis companies, in terms of their management,” he said. “Along with this has come basically a rush of investors who are looking to get in on the action, because the types of returns you can get from investment in a cannabis company are significantly more beneficial to investors than a typical early stage venture capital.”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”